HIMSSCast: Epic leaders on data-driven clinical trial innovation

HIMSSCast: Epic leaders on data-driven clinical trial innovation

The challenges of designing effective clinical trials, finding the right people to participate in them and building trial cohorts that are representative of the population at large, have been well-documented.With its recent Life Sciences initiative, Epic has set its sights on data-driven insights to improve the development of new therapeutics and interventions. That includes improving all parts of the clinical trial process – from how physicians educate their patients about potential cohorts, matching and connecting patients with promising research and helping make sure those studies are optimally beneficial for as many people as possible. Epic is already helping its provider customers…

Continue Reading
What the metaverse and virtual reality can contribute to healthcare

What the metaverse and virtual reality can contribute to healthcare

The so-called metaverse and virtual reality are up-and-coming technologies that could offer healthcare quite a bit.Medical practitioners can test out the effectiveness of new surgical methods in the metaverse before attempting on real patients. And as an extension of telehealth, medical professionals can use virtual reality to access patients and examine them virtually.
What exactly is the metaverse? How does virtual reality work? What can they contribute to healthcare? And where will these technologies offer innovations in the years to come?
To get answers to these questions, we sat down with Pari Natarajan, CEO of Zinnov, a global management and consulting firm focusing…

Continue Reading
Q&A: How the PHE's end could affect telehealth, patient care

Q&A: How the PHE’s end could affect telehealth, patient care

The public health emergency declared in early 2020 was put in place to provide waivers from the Centers for Medicare and Medicaid Services to ease the burden on hospitals and other providers during the pandemic. It has been extended 12 times since its implementation and is finally slated to end on May 11. Heather Meade, principal at Washington Council Ernst & Young, spoke with MobiHealthNews about how the end of the PHE could affect telemedicine companies’ funding streams and patients’ access to care.  
MobiHealthNews: What are the benefits and detriments to the PHE ending, especially for telehealth?
Meade: I mean, we need permanent policy…

Continue Reading
Retail disruptors face big strategy questions in 2023, says AHA

Retail disruptors face big strategy questions in 2023, says AHA

A new report from the American Hospital Association Center for Health Innovation explores how retail companies and tech giants like Apple and Google will drive transformational change in healthcare delivery in 2023 and beyond.WHY IT MATTERS
With billions of dollars invested this past year, such as CVS Health’s purchase of Signify Health, the AHA report highlights retail healthcare companies having grabbed significant market share in primary care, concierge medicine, virtual care and in-home medical services. 
They’ve also broadened their reach into pharmacy benefits management, behavioral health and other areas, said AHA researchers in the report.
One example is Amazon. While the company is in the process of buying…

Continue Reading
Report: Pharma R&D ROI Falls to Lowest Level in 13 Years

Report: Pharma R&D ROI Falls to Lowest Level in 13 Years

What You Should Know:– Deloitte Centre for Health Solutions releases its thirteenth annual report, ‘Seize the Digital Momentum: Measuring the return from pharmaceutical innovation 2022’ that explores the performance of the biopharmaceutical industry (bio Pharma) and its ability to generate returns from investment in innovative new medicines.– Since 2021, much of the world has successfully adjusted to life where COVID-19 is more endemic as vaccines and treatments reduced the risk and severity of illness, however geopolitical turmoil and a global cost-of-living crisis have continued to drive serious instability in the health landscape.Pharmaceutical Innovation – Trends and Insights At a GlanceThis is…

Continue Reading
From Telemedicine to Complete Virtual Care and Beyond

From Telemedicine to Complete Virtual Care and Beyond

Michael Gorton, CEO of Recuro HealthTelemedicine has helped improve the quality of life of patients in every corner of the world and has been successfully utilized to provide convenient care to people with limited or no access to health services. Today, worldwide digital interconnectivity is growing, enabling telehealth to advance health equity, bring access to care for underserved regions and meet the urgent, primary and behavioral healthcare needs of an exploding global population.It has been a remarkable journey for the innovators who pioneered telemedicine. Since its inception, digital health services began the transformation from traditional healthcare — a reactive, disease-focused model…

Continue Reading
Ensuring digital health solutions help, not harm

Ensuring digital health solutions help, not harm

A healthcare risk prediction algorithm used on more than 200 million people across the country was found to demonstrate racial bias.One-third of the top 100 hospitals in the U.S. were found to be using a tracking tool called Meta Pixel to collect and send patients’ personal health information to Facebook without their consent.
Pulse oximeters – digital products that use infrared light beams to measure the amount of oxygen in the blood – have transformed the way we care for people with conditions from heart failure to COVID, but are inaccurate for people with dark skin.
How do these egregious practices pass through…

Continue Reading
Digital as the Differentiator for Biopharma and Medtech

Digital as the Differentiator for Biopharma and Medtech

With the Inflation Reduction Act now on the books, the U.S. Centers for Medicare & Medicaid Services (CMS) will begin negotiating drug prices with the pharmaceutical industry. That, combined with other headwinds such as increased competition from me-too drugs, and ever-present pricing pressure from payers, means that pharma players now more than ever need a new and powerful tool to differentiate their products. We believe the next decade of transformation is digital.
Learning from the auto industry Almost every industry has had to confront a fundamental existential question: What is our product? Consider the automotive industry, which once was largely about hardware…

Continue Reading